Skip to main content
. 2014 Jul 26;6(3):278–287. doi: 10.4252/wjsc.v6.i3.278

Table 1.

Mesenchymal stem cells phenotypic characteristics

Positive marker Negative marker Pluripotency Ref.
ISCT criteria Human MSC CD73, CD90, CD105 CD34, CD45, CD11b or CD14, CD19 or CD79α, HLA-DR Osteogenic Chondrogenic Adipogenic [38]
In AA experimental studies Mouse BM-MSC CD44, CD106, Sca-1 CD11b, CD31, CD34, CD45, CD86, CD117 Osteogenic Chondrogenic Adipogenic [51,53]
Human placental-MSC CD29, CD44, CD73, CD90, CD105 CD14, CD19, CD34, CD45, HLA-DR Data not shown [54]
Rat BM-MSC CD44, CD73, CD90, CD105 CD11b, CD45 Data not shown [56]
Pig ASC CD73, CD90, CD105 CD14, CD11b Osteogenic Chondrogenic Adipogenic [57]
Pig BM-MSC CD13, CD29 CD31, CD34, CD45 Data not shown [58]

ISCT: International society of cell therapy; MSC: Mesenchymal stem cell; AA: Aortic aneurysm; BM-MSC: Bone marrow-derived MSC; HLA-DR: Human leukocyte antigen-DR; ASC: Adipose tissue-derived MSC.